世界の血糖値監視用消耗品市場2021年-2026年

◆英語タイトル:Blood Glucose Monitoring Consumables Market - Global Outlook and Forecast 2021-2026

Arizton Advisory & Intelligenceが発行した調査報告書(ARZT21MY024)◆商品コード:ARZT21MY024
◆発行会社(リサーチ会社):Arizton Advisory & Intelligence
◆発行日:2021年4月
◆ページ数:263
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD3,750 ⇒換算¥555,000見積依頼/購入/質問フォーム
5 UserUSD4,250 ⇒換算¥629,000見積依頼/購入/質問フォーム
Corporate UserUSD5,250 ⇒換算¥777,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

本書では、世界の血糖値監視用消耗品市場を調査対象とし、調査手法、調査目的、調査プロセス、範囲、仮定・注意、市場概要、イントロダクション、市場機会・動向、市場成長要因、市場阻害要因、市場状況、製品別(検査ストリップ、ランセット・ランシング装置、CGMセンサー)分析、流通チャネル別(オンライン、オフライン)分析、エンドユーザー別(個人、病院・クリニック、その他)分析、地域別分析、競争状況、主要企業情報、その他企業など、以下の構成でまとめております。
・調査手法
・調査目的
・調査プロセス
・範囲
・仮定・注意
・市場概要
・イントロダクション
・市場機会・動向
・市場成長要因
・市場阻害要因
・市場状況
・世界の血糖値監視用消耗品市場規模:製品別(検査ストリップ、ランセット・ランシング装置、CGMセンサー)
・世界の血糖値監視用消耗品市場規模:流通チャネル別(オンライン、オフライン)
・世界の血糖値監視用消耗品市場規模:エンドユーザー別(個人、病院・クリニック、その他)
・世界の血糖値監視用消耗品市場規模:地域別
・競争状況
・主要企業情報
・その他企業

BLOOD GLUCOSE MONITORING CONSUMABLES INDUSTRY INSIGHTS
The global blood glucose monitoring consumables market size was valued at USD 14.14 billion to reach USD 29 billion by 2026, growing at a CAGR of 13% during the forecast period. The market has witnessed significant growth due to the growing prevalence of diabetes and the increasing awareness of self-management of diabetes.
The prevalence of diabetes worldwide increases at an alarming rate due to changing lifestyles, growing alcohol consumption, and increasing smokers. However, the outbreak of the COVID-19 pandemic and the introduction of technologically advanced blood glucose test strips and lancets influence the digital diabetes management market’s growth. The increased demand for self-care/homecare devices is also contributing to the usage of BGM consumables. With an increase in the sale of blood glucose meters, test strips, and lancets, the market offers tremendous growth opportunities for global, regional, and local vendors. Therefore, many vendors strategically focus on the development and commercial launches for regular blood glucose monitoring, which increases the demand for consumables.
SNIPPETS
• Test strips are likely to reach a revenue share of over USD 13 billion by 2026 due to the high application of these consumables among hospitals and individual patients.
• Sensors are expected to grow at the highest CAGR of approx. 28% during the period 2020–2026 on account of the increasing popularity of non and minimal-invasive devices.
• Online distribution channels project to observe an incremental growth of approx. USD 9 billion by 2026 due to the digitization of pharmacies and the outbreak of the COVID-19 pandemic.
• Hospitals and clinics expect to grow at a CAGR of approx. 11% by 2026 because of the high consumption of consumables such as test strips and lancets in these settings.
• North America is projected to touch revenue over approx. USD 15 billion by 2026 due to the high prevalence of the diabetic population and increased awareness of consumables.
GLOBAL BLOOD GLUCOSE MONITORING CONSUMABLES MARKET SEGMENTATION
This research report includes a detailed segmentation by
• Products
• End-users
• Distribution Channel
• Geography
INSIGHTS BY PRODUCTS
Test strips accounted for over 64% of the global blood glucose monitoring consumables market in 2020. As revenues from test strips are recurring, vendors strategize to maximize sales volume and profit margins by offering innovative products. However, the growing use of self-monitoring blood glucose testing by patients and professionals in several POC testing sites such as emergency care, physician offices, ambulatory settings, and nursing homes increases test strips’ consumption. Hospitals across the world have been using test strips for superfast output and nearly accurate results. These factors have increased the demand for test strips in the market.
The continuous glucose monitoring (CGM) sensors segment is likely to grow at an incremental revenue of over USD 10 billion by 2026. The incorporation of smart and user-friendly features with increased accuracy expect to drive the application of sensors. The introduction of non- and minimal invasive sensors is also boosting the market growth. Manufacturers are using electrochemical, optical, piezoelectric-based sensors in the commercialized CGM systems. The use of minimally invasive CGM sensors using the electrochemical sensing technique is on the rise. However, over the past decade, commercial-grade CGM sensors have lost their steam compared to SMBG systems. Vendors are focusing on developing advanced, accurate sensors. One of the major factors driving the growth of sensors is the size reduction and increased lifespan of these devices, which are considered essential factors for high adoption.
INSIGHTS BY END-USERS
In 2020, the end-user segment was segmented into individuals, hospitals and clinics, and others. The individual’s segment accounted for the highest share of the market with 75%. The individual segment accounts for the highest share due to the wide acceptance of SMBG monitoring devices and consumables such as test strips, lancets, and lancing devices among consumers. The acceptance of these consumables and machines is confined to developed countries and in developing and underdeveloped countries, which has influenced their revenue growth. SMBG and continuous glucose monitoring devices use sensors, lancets, lancing devices, and test strips as consumables to measure blood glucose. The usage of CMBG is higher in developed countries such as the US and UK, France, Spain, Italy, and Germany due to the increased awareness of these devices and reimbursement options.
The global blood glucose monitoring consumables market by hospitals & clinics is expected to reach approx. USD 5 billion by 2026. Consumables have been widely used devices in ambulatory settings and hospitals. They became a preferred choice among medical professionals during the COVID-19 pandemic for monitoring blood glucose levels. The use of BGM devices among professionals in hospitals and clinics is also on the rise. Furthermore, the introduction of favorable government initiatives and reimbursement options for blood glucose monitoring are fueling the market growth.
INSIGHTS BY DISTRIBUTION CHANNEL
Online distribution channels are increasing significantly, although retail channels are maintaining their lead. Online purchasing channels expect to grow at a CAGR of over 12% during the forecast period. However, retail stores continue to be preferred for purchasing consumables and BGM devices in low- and middle-income countries. As the older generation patients prefer retail chains to purchase blood glucose consumables, the X generation prefers online channels for consumables due to high smartphone penetration. With the outbreak of the COVID-19 pandemic, most offline pharmacies were closed, which directly boosted consumables’ sales via online channels. Hospital pharmacies, standalone pharmacies, and other retail pharmacies are the primary retail offline mode of distribution. Around 80% of BGM devices & consumables sales occur via retail channels in low- and middle-income countries.
INSIGHTS BY GEOGRAPHY
In 2020, North America dominated the market due to its developed healthcare infrastructure and increased awareness of diabetics among patients. The usage of continuous blood glucose monitoring sensors, test strips, lancets, and lancing devices is high among patients. The impact of COVID-19 has been increased in the region, with the US accounting for the highest infection rates.
In 2020, Europe was the second-largest contributor and accounted for approx. 30% in the blood glucose monitoring consumables market share. Germany occupies the largest market share in the Europe region. Healthcare facilities, availability of reimbursement policies, and increasing prevalence are promoting growth in the market. In the APAC region, growing population and diabetes prevalence are considered major contributors to the blood glucose monitoring consumables market growth. In the APAC region, the test strips, lancets, and lancing devices are high compared to the CGM sensors in the market.
INSIGHTS BY VENDORS
Medtronic, F. Hoffmann-La Roche, LifeScan, Abbott Laboratories, and Ascensia are the major global players in the blood glucose consumables market. New product approvals/launches coupled with increased R&D activities are the major strategies implemented by vendors to expand presence, drives the market growth, and sustain the market position. Vendors are actively launching innovative devices to penetrate and tap the high growth potential of the market. Vendors are aggressively engaged in R&D activities and plan to launch several innovative products in the coming years. For instance, Abbott, F. Hoffmann-La Roche, Medtronic, Dexcom, LifeScan, and Ascensia Diabetes Care dominate the market due to continuous product innovations and launches. Several companies are developing or commercializing products such as CGM sensors with increased lifespan, advanced test strips, lancets, and lancing devices, respectively, for continuous and self-monitoring blood glucose devices in the market.
The global blood glucose monitoring consumables market research report includes in-depth coverage of the industry analysis, market dynamics with revenue and forecast insights for the following segments:
Product
• Test Strips
• Lancets and Lancing Devices
• Sensors
Distribution Channels
• Offline
• Online
End-users
• Hospitals & Clinics
• Individuals
• Others
Geography
• North America
• US
• Canada
• Europe
• UK
• Germany
• France
• Italy
• Spain
• APAC
• China
• India
• Japan
• South Korea
• Australia
• Latin America
• Mexico
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• Saudi Arabia
• Turkey
• South Africa
• Iran

❖ レポートの目次 ❖

1 Research Methodology
2 Research Objectives
3 Research Process

4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.2 Base Year
4.3 Scope of The Study
4.3.1 Market by Product
4.3.2 Market by Distribution Channel
4.3.3 Market by End-user
4.3.4 Market Segmentation by Geography

5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation

6 Market at a Glance
7 Introduction
7.1 Overview

8 Market Opportunities & Trends
8.1 Increasing Demand for Test Strips & Lancets Due To COVID-19
8.2 Technological Advancements in Test Strips & Lancets
8.3 Availability of Large Number Of Generic Test Strips

9 Market Growth Enablers
9.1 Increasing Prevalence Of Diabetes
9.2 Increasing Vendor Focus On Recurring Revenue Through Consumables
9.3 Availability Of Wide Range Of Blood Glucose Monitoring Devices

10 Market Restraints
10.1 High Cost of Consumables & Lack Of Health Insurance
10.2 Presence of Large Undiagnosed Population
10.3 Increasing use Of Unauthorized & Counterfeit Test Strips

11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.2.1 Product
11.2.2 Distribution Channel
11.2.3 End-User
11.2.4 Geography
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry

12 Product
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Test Strips
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.3.3 Test Strips: Geographical Segmentation
12.4 Lancets & Lancing Devices
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.4.3 Lancets & Lancing Devices: Geographical Segmentation
12.5 CGM Sensors
12.5.1 Market Overview
12.5.2 Market Size & Forecast
12.5.3 CGM Sensors: Geographical Segmentation

13 Distribution Channel
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Online
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.3.3 Online: Geographical Segmentation
13.4 Offline
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.4.3 Offline: Geographical Segmentation

14 End-User
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Individuals
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.3.3 Individuals: Geographical Segmentation
14.4 Hospitals &Clinics
14.4.1 Market Overview
14.4.2 Market Size & Forecast
14.4.3 Hospitals & Clinics: Geographical Segmentation
14.5 Others
14.5.1 Market Overview
14.5.2 Market Size & Forecast
14.5.3 Others: Geographical Segmentation

15 Geography
15.1 Market Snapshot & Growth Engine
15.2 Geographic Overview

16 North America
16.1 Market Overview
16.2 Market Size & Forecast
16.3 North America: Product Segmentation
16.4 North America: Distribution Segemntation
16.5 North America: End-User Segmentation
16.6 Key Countries
16.6.1 US: Market Size & Forecast
16.6.2 Canada: Market Size & Forecast

17 Europe
17.1 Market Overview
17.2 Market Size & Forecast
17.3 Europe: Product Segmentation
17.4 Europe: Distribution Segmentation
17.5 Europe: End-User Segmentation
17.6 Key Countries
17.6.1 Germany: Market Size & Forecast
17.6.2 France: Market Size & Forecast
17.6.3 UK: Market Size & Forecast
17.6.4 Italy: Market Size & Forecast
17.6.5 Spain: Market Size & Forecast

18 APAC
18.1 Market Overview
18.2 Market Size & Forecast
18.3 APAC: Product Segmentation
18.4 APAC: Distribution Segmentation
18.5 APAC: End-User Segemntation
18.6 Key Countries
18.6.1 China: Market Size & Forecast
18.6.2 Japan: Market Size & Forecast
18.6.3 India: Market Size & Forecast
18.6.4 South Korea: Market Size & Forecast
18.6.5 Australia: Market Size & Forecast

19 Latin America
19.1 Market Overview
19.2 Market Size & Forecast
19.3 Latin America: Product Segmentation
19.4 Latin America: Distribution Segmentation
19.5 Latin America: End-User Segmentation
19.6 Key Countries
19.6.1 Brazil: Market Size & Forecast
19.6.2 Mexico: Market Size & Forecast
19.6.3 Columbia: Market Size & Forecast
19.6.4 Argentina: Market Size & Forecast

20 Middle East & Africa
20.1 Market Overview
20.2 Market Size & Forecast
20.3 Middle East & Africa: Product Segmentation
20.4 Middle East & Africa: Distribution Channels
20.5 Middle East & Africa: End-User Segmentation
20.6 Key Countries
20.6.1 Turkey: Market Size & Forecast
20.6.2 South Africa: Market Size & Forecast
20.6.3 Saudi Arabia: Market Size & Forecast
20.6.4 Iran: Market Size & Forecast

21 Competitive Landscape
21.1 Competition Overview
21.1.1 Abbott
21.1.2 F. Hoffmann-La Roche
21.1.3 Dexcom
21.1.4 Medtronic
21.1.5 Ascensia Diabetes Care Holdings
21.1.6 LifeScan

22 Key Company Profiles
22.1 Abbott
22.1.1 Business Overview
22.1.2 Product Offerings
22.1.3 Key Strategies
22.1.4 Key Strengths
22.1.5 Key Opportunities
22.2 F. Hoffmann-La Roche
22.2.1 Business Overview
22.2.2 Product Offerings
22.2.3 Key Strategies
22.2.4 Key Strengths
22.2.5 Key Opportunities
22.3 Dexcom
22.3.1 Business Overview
22.3.2 Product Offerings
22.3.3 Key Strategies
22.3.4 Key Strengths
22.3.5 Key Opportunities
22.4 Medtronic
22.4.1 Business Overview
22.4.2 Product Offerings
22.4.3 Key Strategies
22.4.4 Key Strengths
22.4.5 Key Opportunities
22.5 Ascensia Diabetes Care Holdings
22.5.1 Business Overview
22.5.2 Product Offerings
22.5.3 Key Strategies
22.5.4 Key Strengths
22.5.5 Key Opportunities
22.6 Lifescan
22.6.1 Business Overview
22.6.2 Product Offerings
22.6.3 Key Strategies
22.6.4 Key Strengths
22.6.5 Key Opportunities

23 Other Prominent Vendors
23.1 77 ELEKTRONIKA KFT.
23.1.1 Business Overview
23.1.2 Product Offerings
23.2 Arkray
23.2.1 Business Overview
23.2.2 Product Offerings
23.3 A. Menarini Diagnostics
23.3.1 Business Overview
23.3.2 Product Offerings
23.4 Agamatrix
23.4.1 Business Overview
23.4.2 Product Offerings
23.5 Alliance International
23.5.1 Business Overview
23.5.2 Product Offerings
23.6 B. Braun Melsungen
23.6.1 Business Overview
23.6.2 Product Offerings
23.7 Bionime
23.7.1 Business Overview
23.7.2 Product Offerings
23.8 Bioptik
23.8.1 Business Overview
23.8.2 Product Offerings
23.9 Biotest Medical
23.9.1 Business Overview
23.9.2 Product Offerings
23.10 BTNX
23.10.1 Business Overview
23.10.2 Product Offerings
23.11 Easymax
23.11.1 Business Overview
23.11.2 Product Offerings
23.12 I-SENS
23.12.1 Business Overview
23.12.2 Product Offerings
23.13 IHealth Labs
23.13.1 Business Overview
23.13.2 Product Offerings
23.14 MED Trust
23.14.1 Business Overview
23.14.2 Product Offerings
23.15 Medisana
23.15.1 Business Overview
23.15.2 Product Offerings
23.16 Major Biosystem
23.16.1 Business Overview
23.16.2 Product Offerings
23.17 SANOFI
23.17.1 Business Overview
23.17.2 Product Offerings
23.18 Taidoc Technology
23.18.1 Business Overview
23.18.2 Product Offerings
23.19 Terumo
23.19.1 Business Overview
23.19.2 Product Offerings
23.20 Trividia Health
23.20.1 Business Overview
23.20.2 Product Offerings
23.21 Bioland Technology
23.21.1 Business Overview
23.21.2 Product Offerings
23.22 Rossmax International
23.22.1 Business Overview
23.22.2 Product Offerings
23.23 E-Linkcare Meditech
23.23.1 Business Overview
23.23.2 Product Offerings
23.24 DIAGNOSIS S.A
23.24.1 Business Overview
23.24.2 Product Offerings
23.25 Microlife
23.25.1 Business Overview
23.25.2 Product Offerings
23.26 HMD
23.26.1 Business Overview
23.26.2 Product Offerings
23.27 YPSOMED
23.27.1 Business Overview
23.27.2 Product Offerings
23.28 National Diagnostics Products
23.28.1 Business Overview
23.28.2 Product Offerings
23.29 Norditalia
23.29.1 Business Overview
23.29.2 Product Offerings
23.30 IME-DC
23.30.1 Business Overview
23.30.2 Product Offerings

24 Report Summary
24.1 Key Takeaways
24.2 Strategic Recommendations

25 Quantitative Summary
25.1 Market By Geography
25.2 Market By Product
25.2.1 Lancets & Lancing Devices
25.2.2 Test Strips
25.2.3 Sensors
25.2.4 North America: Product Segmentation
25.2.5 Europe: Product Segmentation
25.2.6 APAC: Product Segmentation
25.2.7 Latin America: Product Segmentation
25.2.8 Middle East & Africa: Product Segmentation
25.3 Market By End-User
25.3.1 Hospitals & Clinics
25.3.2 Individuals
25.3.3 Others
25.3.4 North America: End-user Segmentation
25.3.5 Europe: End-user Segmentation
25.3.6 APAC: End-user Segmentation
25.3.7 Latin America: End-user Segmentation
25.3.8 Middle East & Africa: End-user Segmentation
25.4 Market By Distribution Channel
25.4.1 Offline Distribution
25.4.2 Online Distribution
25.4.3 North America: Distribution Channel
25.4.4 Europe: Distribution Channel
25.4.5 APAC: Distribution Channel
25.4.6 Latin America: Distribution Channel
25.4.7 Middle East & Africa: Distribution Channel

26 Appendix
26.1 Abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の血糖値監視用消耗品市場2021年-2026年(Blood Glucose Monitoring Consumables Market - Global Outlook and Forecast 2021-2026)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆